Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
Nijs M, Wajs E, Aluisio L, Turkoz I, Daly E, Janik A, Borentain S, Singh JB, DiBernardo A, Wiegand F.
Nijs M, et al. Among authors: borentain s.
Int J Neuropsychopharmacol. 2020 Jul 29;23(7):426-433. doi: 10.1093/ijnp/pyaa027.
Int J Neuropsychopharmacol. 2020.
PMID: 32270176
Free PMC article.
Clinical Trial.